Spots Global Cancer Trial Database for basal cell nevus syndrome bcns
Every month we try and update this database with for basal cell nevus syndrome bcns cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome | NCT04893486 | BCCs in Gorlin ... | PTX-022 Vehicle compara... | 18 Years - | Palvella Therapeutics, Inc. | |
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) | NCT03703310 | Basal Cell Nevu... | Patidegib Topic... Patidegib Topic... | 18 Years - | PellePharm, Inc. | |
Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas | NCT02828111 | Basal Cell Carc... | Patidegib Vehicle gel | 18 Years - 85 Years | PellePharm, Inc. | |
Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas | NCT02828111 | Basal Cell Carc... | Patidegib Vehicle gel | 18 Years - 85 Years | PellePharm, Inc. | |
CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome | NCT04893486 | BCCs in Gorlin ... | PTX-022 Vehicle compara... | 18 Years - | Palvella Therapeutics, Inc. |